New Retina Radio by Eyetube - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

New Retina Radio by Eyetube — Science
New Retina Radio by Eyetube

New Retina Radio is a place to hear stories about retina that are told nowhere else.

Copyright: © 2020 Bryn Mawr Communications LLC

Latest Episodes:

[Back to Practice] Academic Settings in a Pandemic: Rules and Regulations Oct 01, 2020

Show notes

The internal regulations governing academic institutions were tested during the COVID-19 surges of spring and summer. As we move into autumn, how effective have they been—and are any worth revisiting? New Retina Radio host John Kitchens, MD, reviews this topic with Dilraj Grewal, MD, from the Duke Eye Center; Adrienne Scott, MD, from the Wilmer Eye Institute; and Elliott Sohn, MD, from University of Iowa to gain a better understanding of how institutional safeguards kept patients and staff safe, and how they may have served as (sometimes necessary) roadblocks to getting practice back to pre-pandemic levels.

This editorially independent podcast is supported with advertising.

[Back to Practice] Educating the Next Generation of Surgeons During COVID-19 Sep 16, 2020

Show notes

The disruptions to clinical and surgical workflows during the COVID-19 crisis are obvious. Less apparent are the downstream effects of adjustments to educational experiences. New Retina Radio host John Kitchens, MD, invites three leaders in academic retina—Sophie Bakri, MD, of the Mayo Clinic; Julia Haller, MD, of Wills Eye Hospital; and R.V. Paul Chan, MD, MSc, MBA, of the University of Illinois at Chicago—to discuss how training and selection of fellows has been altered during the COVID-19 pandemic, and to review the tactics their institutions have employed to mitigate the interference their programs have endured.

This editorially independent podcast is supported with advertising.

jCell Therapy for Retinitis Pigmentosa and Phase 2B Data Aug 31, 2020

Show notes

Approaches to treating retinitis pigmentosa have included prosthetic devices and gene therapy. What if there was an approach that could treat the nearly 2 million worldwide patients with disease? Anthony Joseph, MD, discusses jCell technology, which may work independently of a patient’s genetic subtype to promote photoreceptor survival in retinitis pigmentosa patients. What data from a phase 2b trial were used to evaluate the efficacy of jCell technology? How will the therapy be tested going forward? What safety concerns should clinicians be aware of? Dr. Joseph has some answers.

This editorially independent podcast is supported with advertising.

[Back to Practice] What Happens During a COVID-19 Resurgence? Aug 28, 2020

Show notes

A COVID-19 resurgence seems increasingly likely as autumn and winter approach the United States, forcing people indoors and increasing transmission risk. What can retina clinicians learn from the spring and summers waves of COVID-19 infections that could be applied to the cooler months of 2020? John W. Kitchens, MD, invites Steve Charles, MD; Amy Schefler, MD; and Jayanth Sridhar, MD, to gameplan the future of retina clinics.

This editorially independent podcast is supported with advertising.

[Back to Practice] Technology and COVID-19: Necessity Is the Mother of Invention Aug 26, 2020

Show notes

Retina’s ability to adjust to a new environment should be commended. Which of the technologies introduced during the COVID-19 era are stopgaps and which will be a permanent part of the treatment landscape? John W. Kitchens, MD (United States), is joined by María H. Berrocal, MD (United States); Jean-Francois Korobelnik, MD, PhD (France); and Manish Nagpal, MBBS, MS, FRCS (Edin) (India), to forecast the future of retina’s technologic milieu.

This editorially independent podcast is supported with advertising.

Treat-and-Extend in the Real World Aug 21, 2020

Show notes

Treat-and-extend therapy is a common tactic employed by retina specialists for treating wet AMD patients. What new data will grow the body of information retina specialists already draw on when making decisions about treatment regimen? Michael Singer, MD, shares details from a retrospective review of patient data over a 2-year period during which treat-and-extend regimens were employed.

This editorially independent podcast is supported with advertising.

Opioid Prescribing Patterns Among Retina Specialists Aug 12, 2020

Show notes

In the midst of the COVID-19 pandemic, medicine cannot forget about the raging opioid epidemic taking place in the United States. What role to retina specialists play in fueling the opioid crisis, and how has their behavior changed for the better over time? Yoshihiro Yonekawa, MD, shares his research about opioid prescribing rates among retina specialists, tracing the field’s behavior over time, and offering a window into the specialty’s role in the crisis.

This editorially independent podcast is supported with advertising.

Continuous Dosing in LADDER Aug 04, 2020

Show notes

The phase 2 LADDER study showed the Port Delivery System for ranibizumab was worthy of a phase 3 trial. Was the device able to deliver a continuous dose of therapy that was similar to what you’d find in monthly injection patients? Dilsher Dhoot, MD, reviews the pharmacokinetic data that researchers used to determine the rate of drug release and therapeutic benefit and previews the phase 3 ARCHWAY trial.

This editorially independent podcast is supported with advertising.

[Back to Practice] COVID-19 Clinical and Surgical Protocols: Which Changes Are Here to Stay? Aug 03, 2020

Show notes

Protocols for clinical and surgical settings have been altered in the COVID-19 era. Which of those protocols are temporary, and which protocols will be a permanent part of practice? To answer this question, New Retina Radio host John W. Kitchens, MD, invites María Ana Castellanos-Martinez, MD (Mexico) and Matteo Forlini, MD (Italy) for a roundtable discussion on the future of retina care in the wake of COVID-19–related changes.

This editorially independent podcast is supported with advertising.

[Back to Practice] Education as In-Person Meetings Are Paused Jul 30, 2020

Show notes

Conferences are an essential dynamic to the retina ecosystem that have been disrupted during the COVID-19 crisis. How will the field advance without in-person meetings? New Retina Radio host John W. Kitchens, MD, invites EURETINA General Secretary Anat Loewenstein, MD, and ASRS President Timothy G. Murray, MD, MBA, to discuss the future of in-person education, the evolving dynamics of physician-industry collaboration, and the solutions that retina societies have relied on to maintain retina’s camaraderie.

This editorially independent podcast is supported with advertising.

Related Podcasts